Innovation makes people healthier
The company has rich R & D pipelines and strategic layout at home and abroad. It has cooperative R & D centers in Europe, the United States and other countries. It has three domestic first-class R & D centers with independent intellectual property rights in Jinan and Tai'an. Quality research follows the latest international concept of "quality comes from design". The maximum single impurity is less than 0.02, far higher than the international USP standard.
About Risen-sun Pharma
Shandong Risen-Sun Pharmaceutical Co. LTD
Shandong Risen-Sun Pharmaceutical Co. LTD was established in 2013, is a wholly-owned subsidiary of Jewim Pharmaceutical(Shandong) Co., Ltd with a registered capital of 110 million yuan; the company has two factories: high-tech plant (derived from Jewim separation) and Ningyang plant; the first phase of the Ningyang plant project started construction in 2021, completed construction in 2023, the first phase of the project investment of 400 million yuan, has been put into use. The company covers a total area of 204000㎡, including 42667㎡ of high-tech factory area and 161332㎡ of Ningyang factory area. The company has more than 220 employees, of which college degree or above accounts for 92.7%. The company mainly focuses on the production, R & D and customization of characteristic APIs and advanced pharmaceutical intermediates such as respiratory system, mental system, glucocorticoid and antineoplastic.
Contact us
Online message
A respected pharmaceutical enterprise with professional competitive advantage and international competitiveness